- CH₣46.96bn
- CH₣50.68bn
- CH₣6.53bn
Brief: Lonza Expands Strategic Collaboration With Leading Us Biopharmaceutical Company
Europe Research Roundup: Domino's Pizza Group, L'Oreal, RWE
Swiss stocks - Factors to watch on June 23
Brief: Lonza Group AG Restates 2025 HY Financials Includes Updated Consolidated Income Statement And Key Performance Measures
Table: Swiss trade surplus at CHF 6.11 bln in May
Swiss stocks - Factors to watch on June 16
Brief: Lonza Group Issues Exclusive License To Antharis Therapeutics To Advance Next-Generation Dual Payload ADCS For Gastrointestinal Cancers
Europe Research Roundup: ASML Holding, Douglas, Richemont
Table: Swiss trade surplus at CHF 3.098 bln in April
Europe Research Roundup: Belimo Holding, CTS Eventim, HSBC
Swiss stocks - Factors to watch on May 8
Brief: Lonza Confirms FY Outlook 2026
Media: Banks kick off talks on Lone Star’s $1.75 billion Lonza unit debt - Bloomberg News
Table: Swiss trade surplus at CHF 3.18 bln in March
Europe Research Roundup: Glencore, Naturgy, Temenos
Swiss stocks - Factors to watch on April 14
Swiss stocks - Factors to watch on April 1
Table: Swiss trade surplus at CHF 4.20 bln in February
Lonza And Genetix Biotherapeutics Extend Commercial Manufacturing Agreement For Zynteglo